Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zogenix Inc (ZGNX)

Zogenix Inc (ZGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,414,110
  • Shares Outstanding, K 44,255
  • Annual Sales, $ 0 K
  • Annual Income, $ -123,910 K
  • 60-Month Beta 2.00
  • Price/Sales 1,420.06
  • Price/Cash Flow N/A
  • Price/Book 9.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.04
  • Number of Estimates 6
  • High Estimate -0.89
  • Low Estimate -1.17
  • Prior Year -0.53
  • Growth Rate Est. (year over year) -96.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.05 +9.59%
on 01/07/20
57.22 -4.14%
on 01/17/20
+2.79 (+5.36%)
since 12/20/19
3-Month
40.07 +36.89%
on 11/08/19
57.22 -4.14%
on 01/17/20
+11.36 (+26.12%)
since 10/22/19
52-Week
35.25 +55.60%
on 04/18/19
57.22 -4.14%
on 01/17/20
+12.45 (+29.36%)
since 01/22/19

Most Recent Stories

More News
Zogenix Inc Has Returned 24.6% Since SmarTrend Recommendation (ZGNX)

SmarTrend identified an Uptrend for Zogenix Inc (NASDAQ:ZGNX) on November 14th, 2019 at $45.40. In approximately 2 months, Zogenix Inc has returned 24.65% as of today's recent price of $56.59.

ZGNX : 54.85 (+0.55%)
The Lancet Publishes Phase 3 Trial Results for Zogenix Investigational Drug FINTEPLA(R) in Dravet Syndrome

FINTEPLA as adjunctive therapy showed a significant, dose-dependent reduction in convulsive seizure frequency in Dravet syndrome patients versus placebo

ZGNX : 54.85 (+0.55%)
Zogenix Inc Rises 5.32% on Heavy Volume: Watch For Potential Pullback

Zogenix Inc (NASDAQ:ZGNX) traded in a range yesterday that spanned from a low of $50.31 to a high of $52.83. Yesterday, the shares gained 5.3%, which took the trading range above the 3-day high of $50.31...

ZGNX : 54.85 (+0.55%)
Relatively Good Performance Detected in Shares of Zogenix Inc in the Pharmaceuticals Industry (ZGNX , DERM , PFE , RVNC , LCI )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 18.83 (-1.67%)
PFE : 40.19 (-0.37%)
ZGNX : 54.85 (+0.55%)
Zogenix Inc Rises 1.03% on Heavy Volume: Watch For Potential Pullback

Zogenix Inc (NASDAQ:ZGNX) traded in a range yesterday that spanned from a low of $47.09 to a high of $48.13. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $47.61...

ZGNX : 54.85 (+0.55%)
Zogenix to Host Investor Update Lunch on FINTEPLA(R) at the American Epilepsy Society 2019 Annual Meeting

Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will host an Investor Update Lunch on its investigational drug, FINTEPLA(R) (ZX008,...

ZGNX : 54.85 (+0.55%)
Zogenix Inc Falls 2.38% on Heavy Volume: Watch For Potential Rebound

Zogenix Inc (NASDAQ:ZGNX) traded in a range yesterday that spanned from a low of $45.78 to a high of $46.95. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $45.78...

ZGNX : 54.85 (+0.55%)
Shares of ZGNX Up 3.4% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Zogenix Inc (NASDAQ:ZGNX) on November 14th, 2019 at $45.40. In approximately 3 weeks, Zogenix Inc has returned 3.44% as of today's recent price of $46.96.

ZGNX : 54.85 (+0.55%)
JAMA Neurology Publishes Phase 3 Study of Zogenix Investigational Drug FINTEPLA(R) in Dravet Syndrome Patients Taking Stiripentol-Containing Antiepileptic Drug Regimens

Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, announced today that JAMA Neurology has published the results of Zogenix's Phase 3 study (Study 1504) of...

ZGNX : 54.85 (+0.55%)
Zogenix to Present New Data for Its Investigational Drug FINTEPLA(R) at the American Epilepsy Society Annual Meeting

Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, announced that data from eight abstracts related to its investigational therapy, FINTEPLA(ZX008, fenfluramine...

ZGNX : 54.85 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ZGNX with:

Business Summary

Zogenix is a specialty biopharmaceutical company focused on developing therapies for patients with rare central nervous system conditions that have limited or no treatment options. The company is currently pursuing two therapies targeting the Dravet Syndrome and the Lennox-Gastaut Syndrome.

See More

Key Turning Points

2nd Resistance Point 55.68
1st Resistance Point 55.27
Last Price 54.85
1st Support Level 54.22
2nd Support Level 53.58

See More

52-Week High 57.22
Last Price 54.85
Fibonacci 61.8% 48.83
Fibonacci 50% 46.24
Fibonacci 38.2% 43.64
52-Week Low 35.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar